GlassScriptPhysician profile
Adam J Kaiser
NPI 1972823177
$67,207.35
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,688 · 2021: $19K · 2022: $25K · 2023: $2,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,808 · Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,808.42 |
| Food and Beverage | $620.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $51,824.32 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $8,225.55 | 2019-2023 | Dupixent |
| Amgen INC. | $2,062.69 | 2022-2023 | Tezspire |
| Medtronic, INC. | $1,990.87 | 2023 | Illumisite |
| Veran Medical Technologies, INC. | $1,173.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.06 | 2019-2023 | Ofev |
| Glaxosmithkline, LLC. | $308.17 | 2019-2023 | Nucala, Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $157.72 | 2021-2023 | Uptravi |
| Genzyme Corporation | $148.19 | 2020-2023 | |
| Ethicon US, LLC | $117.12 | 2022 | |
| Mylan Specialty L.P. | $111.46 | 2022-2023 | Yupelri |
| Philips North America LLC | $110.55 | 2019-2022 | |
| Genentech USA, INC. | $86.70 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.60 | 2022-2023 | Glassia |
| Insmed, INC. | $76.09 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $69.93 | 2023 | Prolastin-C Liquid |
| Inogen, INC. | $60.98 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Phadia US INC. | $47.54 | 2019 | |
| Intuitive Surgical, INC. | $44.24 | 2021 | |
| Paratek Pharmaceuticals, INC. | $42.38 | 2022 | |
| Mallinckrodt Hospital Products INC. | $40.54 | 2022 | |
| Covis Pharma Gmbh | $25.53 | 2022 | |
| Merck Sharp & Dohme LLC | $17.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.16 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.56 | 2023 | Airduo Digihaler |
| Baxter Healthcare | $14.21 | 2022 | |
| Pfizer INC. | $12.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.